Arun Singh, MD, Medical Oncologist at UCLA, describes the advantages of mouse models. Certis provides Orthotopic PDX (Patient-Derived Xenograft) mouse models for cancer patients.
About Certis Oncology Solutions
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care. Our patient-directed therapy enables oncologists to tailor and optimize therapies for patients suffering from aggressive cancers. We also provide pre-clinical services for pharmaceutical and biotech companies. The differentiators for all of our services are the Certis Orthotopic PDX techniques. Certis is affiliated with leading cancer physicians at UCLA and Memorial Sloan Kettering.